Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative Chemoradiotherapy for Gastric Cancer
NCT00003862Phase 2Completed
- Sponsor
- NRG Oncology
- Start
- Nov 1999
- Primary completion
- Nov 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of cisplatin, fluorouracil and paclitaxel in gastric cancer (GC), sponsored by NRG Oncology. Primary endpoints: Feasibility of preoperative chemoradiotherapy and Pathologic Complete Response Rate. Started Nov 1999; status: completed.
02
Drugs
cisplatinfluorouracilpaclitaxel
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT00003862.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003862.